CAC
EXAS

Cowen and Company’s Exact Sciences EXAS Stock Holding History

Cowen and Company’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,700
Closed -$6.2K – 650
2024
Q1 		$6.2K Buy
+3,700
New +$234K ﹤0.01% 550
2023
Q1 		– Sell
-23,400
Closed -$50.3K – 607
2022
Q4 		$50.3K Buy
+23,400
New +$956K 0.01% 258
2020
Q1 		– Sell
-15,000
Closed -$11K – 459
2019
Q4 		$11K Buy
+15,000
New +$1.32M ﹤0.01% 387

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cowen and Company's EXAS Position: Q2 2024 in Review

Cowen and Company sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 3,590 shares — an estimated $248K sold.

Cowen and Company first reported a position in EXAS in Q3 2022 and held it in 3 quarters. The position peaked at $1.11M in Q4 2022. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Cowen and Company reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Cowen and Company sold 3,590 Exact Sciences shares in Q2 2024, an estimated $248K.
  • Cowen and Company first reported a position in Exact Sciences in Q3 2022 and held it in 3 quarters.
  • Cowen and Company's Exact Sciences position peaked at $1.11M in Q4 2022.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.